Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple viral replication-related targets is a collective term used to describe a diverse set of proteins and enzymes that viruses utilize to propagate within a host. This category includes essential viral components such as RNA-dependent RNA polymerases, DNA polymerases, proteases, and integrases, as well as host cell factors that viruses hijack for entry and assembly (NIH, 2020: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150111/). Therapeutic strategies often involve targeting these specific stages of the viral life cycle to inhibit the production of new virions and reduce the overall viral burden in the patient (Nature Reviews Microbiology, 2021: https://www.nature.com/articles/s41579-020-00477-w). For instance, nucleoside analogs like Remdesivir target viral polymerases, while protease inhibitors like Ritonavir block the maturation of viral proteins (PubMed, 2022: https://pubmed.ncbi.nlm.nih.gov/32454312/). Because this term encompasses a wide array of distinct molecular structures across different virus families, it does not represent a single, specific therapeutic target but rather a broad pharmacological focus area. Consequently, drug development requires identifying the specific viral protein or host interaction relevant to the particular pathogen being treated (StatPearls, 2023: https://www.ncbi.nlm.nih.gov/books/NBK482410/).
Inhibition of various stages of the viral life cycle, including genome replication, proteolytic processing of viral polyproteins, and blocking of viral entry or exit pathways.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple viral replication-related targets.